c-kit mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation

被引:70
作者
Yanagihori, H [1 ]
Oyama, N [1 ]
Nakamura, K [1 ]
Kaneko, F [1 ]
机构
[1] Fukushima Med Univ, Grad Sch Med, Dept Dermatol, Fukushima 9601295, Japan
关键词
D O I
10.1016/S1525-1578(10)60552-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Mastocytosis represents a clonal proliferation of mast cell hematopoietic progenitors caused by gain-of-function mutations of the c-kit gene. The heterogeneity of c-kit mutations may have contributed to difficulties in characterizing genotype-phenotype correlation of the disease. Our goal was to analyze a set of reported pathogenic c-kit mutations in patients with childhood-onset cutaneous mastocytosis, in comparison with those with adult-onset disease, and to correlate these with clinical presentation. We performed polymerase chain reaction and direct sequencing using genomic DNA samples from 16 nonfamilial Japa nese patients with indolent cutaneous mastocytosis (12 with childhood-onset disease and 4 with adult-onset disease) to look for the most common c-kit mutations at codons 816, 560, 820, and 839. A substantial number of patients had missense codon 816 mutations (10 of 12 in the childhood-onset group, 83.3%; and 4 of 4 in the adult-onset group, 100%). The most common mutation was Asp816Val (9 of 16, 64.3%) followed by Asp816Phe (5 of 16, 35.7%). Moreover, children with the Asp816Phe mutation developed cutaneous mastocytosis at an earlier age as compared to those with the Asp816Val mutation (mean age of onset, 1.3 months versus 5.9 months, respectively; P = 0.068). No other mutation variations were found in our cohort. In summary, we confirmed a high incidence of two distinct c-kit mutations, Asp816Val and Asp816Phe, in patients with childhood-onset cutaneous mastocytosis. Our results provide new insights into common c-kit mutations, which may contribute to different clinical courses of the disease.
引用
收藏
页码:252 / 257
页数:6
相关论文
共 24 条
[1]   A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib [J].
Akin, C ;
Fumo, G ;
Yavuz, AS ;
Lipsky, PE ;
Neckers, L ;
Metcalfe, DD .
BLOOD, 2004, 103 (08) :3222-3225
[2]   URTICARIA-PIGMENTOSA - A REVIEW OF 67 PEDIATRIC CASES [J].
AZANA, JM ;
TORRELO, A ;
MEDIERO, IG ;
ZAMBRANO, A .
PEDIATRIC DERMATOLOGY, 1994, 11 (02) :102-106
[3]  
Beghini A, 2001, CANCER, V92, P657, DOI 10.1002/1097-0142(20010801)92:3<657::AID-CNCR1367>3.0.CO
[4]  
2-D
[5]   Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis:: A possible explanation for divergent clinical behavior [J].
Büttner, C ;
Henz, BM ;
Welker, P ;
Sepp, NT ;
Grabbe, J .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (06) :1227-1231
[6]  
DAVIS LG, 1986, BASIC METHODS MOL BI, P44
[7]   IDENTIFICATION OF MUTATIONS IN THE CODING SEQUENCE OF THE PROTOONCOGENE C-KIT IN A HUMAN MAST-CELL LEUKEMIA-CELL LINE CAUSING LIGAND-INDEPENDENT ACTIVATION OF C-KIT PRODUCT [J].
FURITSU, T ;
TSUJIMURA, T ;
TONO, T ;
IKEDA, H ;
KITAYAMA, H ;
KOSHIMIZU, U ;
SUGAHARA, H ;
BUTTERFIELD, JH ;
ASHMAN, LK ;
KANAYAMA, Y ;
MATSUZAWA, Y ;
KITAMURA, Y ;
KANAKURA, Y .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) :1736-1744
[8]   KIT mutations are common in testicular seminomas [J].
Kemmer, K ;
Corless, CL ;
Fletcher, JA ;
McGreevey, L ;
Haley, A ;
Griffith, D ;
Cummings, OW ;
Wait, C ;
Town, A ;
Heinrich, MC .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (01) :305-313
[9]   A proposed classification of mastocytosis incorporating molecular genetics [J].
Longley, BJ ;
Metcalfe, DD .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2000, 14 (03) :697-+
[10]   Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis [J].
Longley, BJ ;
Metcalfe, DD ;
Tharp, M ;
Wang, XM ;
Tyrrell, L ;
Lu, SZ ;
Heitjan, D ;
Ma, YS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (04) :1609-1614